Stay updated on UC-961 in Relapsed CLL Clinical Trial
Sign up to get notified when there's something new on the UC-961 in Relapsed CLL Clinical Trial page.
Latest updates to the UC-961 in Relapsed CLL Clinical Trial page
- Check3 days agoChange DetectedAdded B-cell chronic lymphocytic leukemia as a condition term and included Genetic and Rare Diseases Information Center as a resources entry.SummaryDifference0.2%
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedRevision history updated: added v3.5.0 and removed v3.4.3.SummaryDifference0.1%
- Check25 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. This update does not modify study data or page content.SummaryDifference0.1%
- Check53 days agoChange DetectedRevision: v3.4.2 was added; the old government funding/status notice was removed, and the core study details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%
- Check60 days agoChange DetectedDifference0.4%
- Check67 days agoChange DetectedAdded a new Study Protocol and Statistical Analysis Plan PDF (2015-06-25, 1.91MB) under Study Documents. Expanded the page with additional metadata including MeSH terms and keywords, and updated verification dates.SummaryDifference59%
Stay in the know with updates to UC-961 in Relapsed CLL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the UC-961 in Relapsed CLL Clinical Trial page.